Lexington Biosciences Introduces Medical Advisory Board
Advisory team prepares to move HeartSentry through clinical studies
Lexington Biosciences Commences Trading on OTC Markets as LXGTF and Introduces Key Board Members
VANCOUVER, BC — (Marketwired) — 07/06/17 — (CSE: LNB) (CNSX: LNB) (OTC PINK: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company operating within the healthcare industry, is pleased to announce it has met the compliance requirements of the Financial Industry Regulatory Authority (FINRA) and has initiated price quotation on OTC Link under the ticker symbol: LXGTF.In related news, the Company wishes to introduce two members of its Board; Mr. R
MOCACARE Expands Heart Health Portfolio with MOCACuff, a State-of-the-Art Blood Pressure Cuff Worn on the Cuff
MOCACuff and the MOCACARE App Deliver Results and Advice Loosening the Grip of Hypertension
Taglich Brothers Initiates Coverage on Trxade Group, Inc.
NEW YORK, NY — (Marketwired) — 11/25/14 — . announces it initiated coverage of . (OTCQB: TRXD).. (OTCQB: TRXD), based in Lutz, Florida, operates an Internet-based exchange that promotes and enables trading among independent pharmacies and pharmaceutical suppliers (wholesalers). Currently, the company–s market platform is used mainly by around 2,300 retail pharmacies to purchase drugs from 24 wholesalers (supplier to pharmacy). Proprietary software enables users of Trxade–s network to compa
FDA to Provide Input for Competing Teams in the $10 Million Qualcomm Tricorder XPRIZE
XPRIZE and FDA Partnership Focused on Expediting Market Entry for New Consumer Technologies in the Mobile Health Space
NCPDP Website Streamlines Access to Up-to-Date Healthcare News and Resources, Standards and Patient Safety Solutions
Features New Design and Improved Navigation